Volume 14, Issue 6, June 2022

Articles

The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation
Soonhwa Song, Joon Kyu Park, Sang Chul Shin, Jae-Jin Lee, Seung Kon Hong, In-Kang Song, Bokyung Kim, Eun Joo Song, Kong-Joo Lee, Eunice EunKyeong Kim
J Mol Cell Biol, Volume 14, Issue 6, June 2022, mjac037, https://doi.org/10.1093/jmcb/mjac037
Abstract | Full Text 
Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia 
Yanan Yang, Guodong Deng, Lili Qiao, Hui Yuan, Xiaohong Yu, Lei Xu, Shih-Hsin Lu, Wei Jiang, Xiying Yu
J Mol Cell Biol, Volume 14, Issue 6, June 2022, mjac038, https://doi.org/10.1093/jmcb/mjac038
Abstract | Full Text 
Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2
Runqiang Chen, Hui Xie, Sahba Khorsandzadeh, Madison Smith, Namir Shaabani, Qidong Hu, Xiaoxuan Lyu, Hua Wang, Wan-lin Lim, Haotian Sun, Henry Ji, Brian Cooley, Russell Ross, David M. Francis
J Mol Cell Biol, Volume 14, Issue 6, June 2022, mjac041, https://doi.org/10.1093/jmcb/mjac041
Abstract | Full Text 
AIM-CICs: an automatic identification method for cell-in-cell structures based on convolutional neural network
Meng Tang, Yan Su, Wei Zhao, Zubiao Niu, Banzhan Ruan, Qinqin Li, You Zheng, Chenxi Wang, Bo Zhang, Fuxiang Zhou, Xiaoning Wang, Hongyan Huang, Hanping Shi, Qiang Sun
J Mol Cell Biol, Volume 14, Issue 6, June 2022, mjac044, https://doi.org/10.1093/jmcb/mjac044
Abstract | Full Text 

Review

Letter to the Editor

Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way 
Otávio Augusto Chaves, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Jairo Ramos Temerozo, Filipe Pereira-Dutra, Daniella M. Mizurini, Robson Q. Monteiro, Leonardo Vazquez, Patricia T. Bozza, Hugo Caire Castro-Faria-Neto, Thiago Moreno L. Souza
J Mol Cell Biol, Volume 14, Issue 6, June 2022, mjac039, https://doi.org/10.1093/jmcb/mjac039
Abstract | Full Text 

Research Advance

Vascularizing the brain organoids
Xin-Yao Sun, Zhen-Ge Luo
J Mol Cell Biol, Volume 14, Issue 6, June 2022, mjac040, https://doi.org/10.1093/jmcb/mjac040
Abstract | Full Text 
Cover: Apixaban is an orally available anticoagulant recommended for prophylactic and therapeutic use for coronavirus disease 2019. Besides its anticoagulant action, apixaban also inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) and the viral replication with a multiplicity of infection-dependent antiviral activity. The image was contributed by Remy Martins-Gonçalves. See mjac039 by Chaves et al. for details.